Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project.

Laoutidis ZG, Konstantinidis A, Grohmann R, Luckhaus C, Mobascher J, Cordes J.

Pharmacopsychiatry. 2015 Jul;48(4-5):178-81. doi: 10.1055/s-0035-1549997. Epub 2015 May 18.

PMID:
25984709
2.

Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.

Atbasoglu EC, Ozguven HD, Can Saka M, Goker C.

J Clin Psychiatry. 2004 Dec;65(12):1724-5. No abstract available.

PMID:
15641884
3.

Amisulpride-induced neuroleptic malignant syndrome.

Abay E, Kose R.

J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):488-9. No abstract available.

PMID:
18070872
4.

Serum creatine kinase elevation associated with olanzapine treatment.

Punukollu B, Rutherford H.

BMJ Case Rep. 2008;2008:bcr0620080040. doi: 10.1136/bcr.06.2008.0040. Epub 2008 Nov 20.

5.

Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.

Angelopoulos P, Markopoulou M, Kyamidis K, Bobotas K.

Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):482-4. doi: 10.1016/j.genhosppsych.2008.03.007. Epub 2008 Jul 23.

PMID:
18774435
6.

[Malignant neuroleptic syndrome associated with amisulpride].

Harter C, Obier C, Druschky KF, Eikelmann B.

Nervenarzt. 2008 Jan;79(1):86-9. German.

PMID:
17924089
7.

Marked elevation of serum creatine kinase associated with olanzapine therapy.

Marcus EL, Vass A, Zislin J.

Ann Pharmacother. 1999 Jun;33(6):697-700.

PMID:
10410183
8.

Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.

Papadimitriou GN, Theleritis CG, Dikeos DG, Psarros CJ, Soldatos CR.

Int Clin Psychopharmacol. 2006 May;21(3):181-4.

PMID:
16528141
9.

Massive creatine kinase elevations with quetiapine: report of two cases.

Klein JP, Fiedler U, Appel H, Quante A, Jockers-ScherĂ¼bl MC.

Pharmacopsychiatry. 2006 Jan;39(1):39-40.

PMID:
16453254
10.

Amisulpride and neuroleptic malignant syndrome.

Tu MC, Hsiao CC.

Chang Gung Med J. 2011 Sep-Oct;34(5):536-40.

11.

Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Laoutidis ZG, Kioulos KT.

Psychopharmacology (Berl). 2014 Nov;231(22):4255-70. doi: 10.1007/s00213-014-3764-2. Epub 2014 Oct 16. Review.

PMID:
25319963
12.

Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.

Holtmann M, Meyer AE, Pitzer M, Schmidt MH.

Pharmacopsychiatry. 2003 Nov;36(6):317-8.

PMID:
14663658
13.

[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].

Pedrosa Gil F, Schneider C, Grohmann R, RĂ¼ther E.

Nervenarzt. 2001 Sep;72(9):729-33. German. Erratum in: Nervenarzt 2001 Nov;72(11):878.

PMID:
11572107
14.

The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.

O'Dwyer AM, Sheppard NP.

Psychol Med. 1993 May;23(2):323-6.

PMID:
8101383
15.

Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.

Kim EY, Kim SH, Lee NY, Jung DC, Kim YS, Ahn YM.

Pharmacopsychiatry. 2012 Mar;45(2):57-63. doi: 10.1055/s-0031-1291175. Epub 2012 Mar 12.

PMID:
22411694
16.

Amisulpride and cardiomyopathy.

Brakoulias V, Bannan E, Cohen P, Geary G.

Aust N Z J Psychiatry. 2005 Aug;39(8):738. No abstract available.

PMID:
16050932
17.

Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.

Lin CH, Wang FC, Lin SC, Huang YH, Chen CC, Lane HY.

Int Clin Psychopharmacol. 2013 Sep;28(5):267-74. doi: 10.1097/YIC.0b013e3283633a83.

PMID:
23778382
18.

Amisulpride-induced hyperprolactinemia is reversible following discontinuation.

Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):92-6. Epub 2006 Aug 28.

PMID:
16938372
19.

[Amisulpride--a neuroleptic agent for all phases of schizophrenia].

[No authors listed]

Nervenarzt. 1999 Mar;70(3 Suppl Amisulprid):1-8. German. No abstract available.

PMID:
10221135
20.

[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].

Barrimi M, El Ghazouani F, Zaimi O, Oneib B.

Presse Med. 2018 Feb;47(2):172-174. doi: 10.1016/j.lpm.2017.11.008. Epub 2018 Feb 1. French. No abstract available.

PMID:
29395559

Supplemental Content

Support Center